Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Checkmate Pharmaceuticals (CMPI)
NASDAQ:CMPI
Checkmate Pharmaceuticals (CMPI) Financial Statements
0 Followers
Checkmate Pharmaceuticals Financial Overview
| Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -15.89M | $ -13.35M | $ -14.98M | $ -18.95M | $ -14.18M |
| EBITDA | $ -15.84M | $ -13.30M | $ -14.98M | $ -18.95M | $ -14.18M |
| Net Income Common Stockholders | $ -15.87M | $ -13.34M | $ -14.97M | $ -18.97M | $ -14.13M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 60.03M | $ 70.87M | $ 80.84M | $ 85.35M | $ 85.81M |
| Total Assets | $ 66.94M | $ 78.84M | $ 89.34M | $ 101.68M | $ 119.71M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -60.03M | $ -70.87M | $ -80.84M | $ -85.35M | $ -85.81M |
| Total Liabilities | $ 11.94M | $ 9.38M | $ 7.81M | $ 6.70M | $ 7.31M |
| Stockholders Equity | $ 55.00M | $ 69.46M | $ 81.53M | $ 94.98M | $ 112.40M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -10.67M | $ -10.16M | $ -14.32M | $ -15.77M | $ -14.31M |
| Operating Cash Flow | $ -10.67M | $ -10.00M | $ -14.02M | $ -15.39M | $ -14.31M |
| Investing Cash Flow | $ -527.00K | $ 6.85M | $ 4.72M | $ 39.36M | $ 10.26M |
| Financing Cash Flow | $ 0.00 | $ 326.00K | $ -314.00K | $ 16.00K | $ 118.00K |
Checkmate Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.